Belustine Capsule (Lomustine) | For Brain Tumors and Hodgkin’s Lymphoma Treatment
Belustine 40 Capsule contains lomustine 40 mg, an anticancer medicine used in the treatment of certain cancers, including brain tumours, lung cancer, Hodgkin lymphoma, and malignant melanoma. It works by interfering with the genetic material of abnormal cells, helping limit their growth.
Product Overview
Belustine Capsule contains lomustine, an oral anticancer medicine belonging to the nitrosourea group of medicines. Belustine is a recognised brand name for lomustine, and the 40 mg strength is listed in medicine references. Confirm the exact strength printed on the product packaging before publishing product-specific details.
Lomustine works by interfering with the DNA and RNA processes that cells need to grow and divide. This action helps limit the growth of abnormal cells and makes it useful in the management of certain cancers under specialist medical supervision.
How Belustine Capsule Works
Lomustine enters cells and interferes with the normal functioning of DNA and RNA. These molecules are essential for cell growth, division and protein production. By disrupting these processes, lomustine helps control the growth of certain abnormal cells.
Lomustine can also cross the blood–brain barrier, which is an important property in its use for selected brain tumours. Its suitability depends on the diagnosis and the overall treatment plan.
Dosage Form and Strength
Belustine is available as an oral capsule. Lomustine capsules are marketed in different strengths, including 10 mg, 40 mg and 100 mg in some markets. The strength and availability of Belustine may differ by country, so verify the product packaging before listing a specific strength.
Importance of Medical Monitoring
Lomustine can affect bone marrow function, which is responsible for producing blood cells. One important characteristic of this medicine is that a reduction in blood cell counts may occur several weeks after a dose rather than immediately.
For this reason, regular blood tests are an essential part of treatment. The oncology team may monitor blood cell counts and assess liver and kidney function as appropriate. These assessments help determine whether the treatment schedule needs to be adjusted.
The timing of monitoring depends on the treatment plan and the individual's clinical circumstances. Follow-up appointments should be maintained even when the person feels well, because some changes may not produce noticeable symptoms at first.
Treatment Planning and Individual Response
The response to lomustine can vary from person to person. The treatment plan depends on the type and stage of the cancer, previous therapies, overall health and laboratory results.
The oncology team evaluates these factors before determining whether lomustine is suitable and how it should be incorporated into treatment. The medicine may be used alone in certain situations or as part of a combination regimen, depending on the clinical indication.
Treatment decisions and any changes to the dosing schedule should be made by the specialist responsible for the patient's care.
Storage and Product Identification
Belustine Capsule should be stored according to the instructions on its original packaging. Keep it in the recommended storage conditions and away from children. Because lomustine requires careful handling, follow the manufacturer's instructions if a capsule is damaged or the contents are accidentally exposed.
Before using or documenting the product, verify the following details:
Product name and manufacturer
- Active ingredient: lomustine
- Strength stated on the capsule packaging
- Expiry date and packaging integrity
- Storage and handling instructions
Summary
Belustine Capsule contains lomustine, an oral nitrosourea medicine used in specialist treatment plans for certain cancers. It works by interfering with the DNA and RNA processes required for cell growth and multiplication. Its ability to cross the blood–brain barrier makes it relevant to selected brain tumour treatments.
The medicine requires an individually determined dosing schedule and regular medical monitoring. For accurate product information on 1mgstore.com, the specific Belustine strength, manufacturer details and formulation should be confirmed from the original packaging before publication.
Precaution
Belustine Capsule contains lomustine, an anticancer medicine that requires careful use and regular monitoring. Follow the oncology team's instructions throughout treatment.
1. Follow the Recommended Dose
Take Belustine Capsule only according to the treatment schedule provided by your specialist. Do not change the dose or repeat it independently.
2. Regular Blood Tests
Lomustine can lower blood cell counts, sometimes several weeks after a dose. Attend scheduled blood tests to monitor your health during treatment.
3. Monitor for Signs of Infection
Contact your healthcare team if you develop a fever, chills, or other signs of infection, as treatment may reduce the body's ability to fight infections.
4. Liver and Kidney Monitoring
Inform your healthcare team about any existing liver or kidney problems. They may recommend appropriate tests during treatment.
5. Pregnancy and Breastfeeding
Lomustine may harm an unborn baby. Discuss pregnancy plans and breastfeeding with your specialist before starting treatment.
Usage
Belustine Capsule contains lomustine, an anticancer medicine used in specialist treatment plans for certain cancers. It works by interfering with the DNA and RNA processes that cells need to grow and divide. Belustine Capsule must be taken strictly according to the treatment schedule provided by the oncology team.
How to Take Belustine Capsule
Take the capsule orally according to your specialist's instructions.
Follow the exact dose and interval provided by your oncology team.
Lomustine is generally taken as a single dose at extended intervals, not as a daily medicine.
Swallow the capsule according to the product instructions. Do not open, crush, or chew it.
Do not repeat a dose or change the treatment schedule independently.
Attend scheduled blood tests to monitor blood cell counts during treatment.
Uses
Belustine Capsule contains lomustine, an anticancer medicine used in specialist treatment plans for certain types of cancer. It works by interfering with the DNA and RNA processes that cells need to grow and divide.
1. Brain Tumours
Lomustine is used to treat certain brain tumours, including selected malignant gliomas. Its ability to cross the blood–brain barrier makes it useful in specific treatment plans.
2. Hodgkin Lymphoma
Belustine may be included in selected treatment regimens for Hodgkin lymphoma, depending on the patient's condition and previous treatments.
3. Other Selected Cancers
Lomustine may be used for certain other cancers in specific clinical situations, depending on specialist assessment and the applicable treatment guidelines.
Important: The exact uses of Belustine Capsule depend on the confirmed product information and the individual's treatment plan. It should be taken only under specialist supervision.
Side Effects
Belustine Capsule contains lomustine, an anticancer medicine that may cause unwanted effects during treatment. The type and severity of these effects can vary between individuals. Some effects, particularly changes in blood cell counts, may appear several weeks after a dose.
Common Effects
Nausea and Vomiting: Feeling sick or vomiting after taking the medicine.
Loss of Appetite: Reduced interest in food or difficulty eating normally.
Tiredness: Feeling unusually weak or lacking energy.
Mouth Sores: Irritation or discomfort inside the mouth.
Hair Loss: Temporary thinning or loss of hair in some individuals.
When to Seek Medical Advice
Contact your oncology team promptly if you develop fever, unusual bruising, bleeding, persistent vomiting, or marked weakness. Seek urgent medical attention for difficulty breathing or other severe symptoms.
Importance of Regular Monitoring
Lomustine can cause delayed bone marrow suppression, so blood cell counts may fall several weeks after treatment. Attend all scheduled blood tests and follow your specialist's monitoring plan.
Important: Belustine Capsule should be used under specialist supervision. Report new or worsening symptoms to your healthcare team rather than adjusting the treatment schedule yourself.
FAQs
1. What is Belustine Capsule?
Belustine Capsule contains lomustine, an anticancer medicine used in specialist treatment plans for certain cancers.
2. How does Belustine Capsule work?
It interferes with the DNA and RNA processes that abnormal cells need to grow and divide.
3. How should Belustine Capsule be taken?
Take it orally according to the exact schedule provided by your oncology team.
4. Is Belustine Capsule taken every day?
No. Lomustine is generally taken at extended intervals, as directed by the treating specialist.
5. Does Belustine Capsule require blood tests?
Yes. Regular blood tests help monitor blood cell counts during treatment.
6. Can Belustine Capsule be combined with other medicines?
Some combinations may affect treatment safety. Inform your specialist about all medicines and supplements you use.
7. What should I do if I miss a dose?
Contact your oncology team for instructions. Do not take an extra dose to compensate.
8. How should Belustine Capsule be stored?
Follow the storage instructions on the original packaging and keep it out of reach of children.
Interactions
Belustine Capsule contains lomustine, an anticancer medicine that may interact with other medicines and affect treatment safety. Inform your oncology team about all medicines, supplements, and herbal products you use before starting treatment.
1. Other Anticancer Medicines
Using lomustine with other medicines that affect bone marrow may increase the risk of low blood cell counts. Your specialist may need to monitor your blood more closely.
2. Medicines Affecting the Immune System
Medicines that suppress immune function may increase the risk of complications when combined with cancer treatment. Tell your specialist about any such medicines you take.
3. Theophylline and Cimetidine
These medicines may increase the risk of bone marrow-related complications when taken with lomustine. Inform your specialist if you use either medicine.
4. Anti-Seizure Medicines
Medicines such as phenobarbital may change how lomustine is processed by the body, potentially affecting treatment response.
5. Radiation Therapy
Combining lomustine with radiation therapy may increase effects on bone marrow and blood cell counts. Your oncology team should coordinate the treatment schedule.
| Manufacturer | : | Mediclone Health Care Pvt Ltd |
| Equivalent Brand | : | Gleostine |
| Generic Search | : | Lomustine |
Latest Products
